Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Return on Invested Capital (2022 - 2026)

Sunshine Biopharma filings provide 4 years of Return on Invested Capital readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q4 2025 for Sunshine Biopharma, down from 0.07% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.07% in Q3 2025 to a low of 0.02% in Q2 2025.
  • Median Return on Invested Capital over the past 4 years was 0.0% (2024), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Invested Capital: up 8bps in 2025, down -2bps in 2025.
  • Sunshine Biopharma's Return on Invested Capital stood at 0.01% in 2022, then skyrocketed by 72bps to 0.0% in 2023, then fell by -18bps to 0.0% in 2024, then rose by 10bps to 0.0% in 2025.
  • The last three reported values for Return on Invested Capital were 0.0% (Q4 2025), 0.07% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.